Esperion Therapeutics Inc (ESPR)

05:19 AM

Esperion Therapeutics Inc. stock momentum explainedJuly 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com

05:19 AM

04:49 AM

Why Esperion Therapeutics Inc. is moving todayMarket Volume Summary & Low Risk Profit Maximizing Plans - newser.com

04:49 AM

04:46 AM

Will Esperion Therapeutics Inc. stock gain from lower inflation2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com

04:46 AM

03:24 AM

Why analysts remain bullish on Esperion Therapeutics Inc. stockQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com

03:24 AM

Oct 13, 2025

Published on: 2025-10-13 11:11:10 - newser.com

Oct 13, 2025

Oct 13, 2025

What analysts say about MarketAxess Holdings Inc stockMarket Liquidity Analysis & Rapid Portfolio Expansion - earlytimes.in

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 10:12:04 - newser.com

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 10:10:18 - newser.com

Oct 13, 2025

Oct 13, 2025

What’s the recovery path for long term holders of Esperion Therapeutics Inc.Treasury Yields & Weekly Market Pulse Updates - newser.com

Oct 13, 2025

Oct 13, 2025

Can Esperion Therapeutics Inc. stock reach $100 price targetEarnings Beat & AI Enhanced Trading Signals - newser.com

Oct 13, 2025

Oct 13, 2025

Why Esperion Therapeutics Inc. stock is favored by top institutions2025 Short Interest & Daily Profit Focused Screening - newser.com

Oct 13, 2025

Oct 13, 2025

How to use a screener to detect Esperion Therapeutics Inc. breakoutsWeekly Market Report & Long Hold Capital Preservation Tips - newser.com

Oct 13, 2025

Oct 13, 2025

How strong is Esperion Therapeutics Inc. stock balance sheet2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025

Oct 12, 2025

Esperion Therapeutics Inc. (ESPR) Stock Price | Live Quotes & Charts | NSD - StocksToTrade

Oct 12, 2025

Oct 11, 2025

Esperion Therapeutics (ESPR): Assessing Valuation After $75 Million Discounted Stock Offering and Share Price Drop - Yahoo Finance

Oct 11, 2025

Oct 10, 2025

Will Esperion Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Fed Impact & Advanced Technical Analysis Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Why Esperion Therapeutics (ESPR) Is Up After $75M Equity Raise and Generic Settlement News - Yahoo Finance

Oct 10, 2025

Oct 10, 2025

How currency fluctuations impact Esperion Therapeutics Inc. stockTake Profit & Fast Momentum Entry Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Why Is Esperion Therapeutics Stock Sinking Premarket Today? - Stocktwits

Oct 10, 2025

Oct 10, 2025

Is Esperion Therapeutics Inc. stock attractive for hedge fundsJuly 2025 Selloffs & Safe Entry Point Identification - newser.com

Oct 10, 2025

Oct 10, 2025

ESPR- Japanese Drug Approval, Otsuka Payments to Help this Biotech Play - Yahoo Finance

Oct 10, 2025

Oct 10, 2025

(10/10/25) ESPR: Japanese Drug Approval, Otsuka Payments to Help this Biote - moneyshow.com

Oct 10, 2025

Oct 09, 2025

ESPR Stock Drops 17% on Pricing of $75M Common Stock Offering - sharewise.com

Oct 09, 2025

Oct 09, 2025

Is Esperion Therapeutics Inc. stock a buy on dips2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com

Oct 09, 2025

Oct 09, 2025

Published on: 2025-10-09 02:49:28 - newser.com

Oct 09, 2025

Oct 09, 2025

Esperion Therapeutics (NASDAQ:ESPR) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 08, 2025

Esperion Announces Public Offering to Raise $70.2 Million - TipRanks

Oct 08, 2025

Oct 08, 2025

Esperion Therapeutics Down Over 15%, on Pace for Largest Percent Decrease Since December 2024 -- Data Talk - 富途牛牛

Oct 08, 2025

Oct 08, 2025

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap DownShould You Sell? - MarketBeat

Oct 08, 2025

Oct 08, 2025

Esperion Therapeutics’ Bold Move: Stock Offering at $2.50 - StocksToTrade

Oct 08, 2025

Oct 08, 2025

Esperion Therapeutics prices $75M public offering - MSN

Oct 08, 2025

Oct 08, 2025

Penguin Solutions Posts Q4 Earnings, Joins Esperion Therapeutics, Joby Aviation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Oct 08, 2025

Oct 08, 2025

Esperion Therapeutics Prices $75 Million Share Offering - MarketScreener

Oct 08, 2025

Oct 07, 2025

Esperion prices $75 million public offering of common stock By Investing.com - Investing.com Nigeria

Oct 07, 2025

Oct 07, 2025

Esperion Announces Pricing of Public Offering of Common Stock - The Manila Times

Oct 07, 2025

Oct 07, 2025

Esperion prices public offering of 30 million shares at $2.50 each - MarketScreener

Oct 07, 2025

Oct 07, 2025

Esperion Therapeutics Announces Pricing of $75 Million Public Offering of Common Stock - Quiver Quantitative

Oct 07, 2025

Oct 07, 2025

Esperion prices $75 million public offering of common stock - Investing.com India

Oct 07, 2025

Oct 07, 2025

$75M Raise — Esperion Prices 30M Shares to Fund Oral LDL‑C Program - Stock Titan

Oct 07, 2025

Oct 07, 2025

Esperion Therapeutics Experiences Evaluation Revision Amidst Mixed Market Indicators and Performance Trends - Markets Mojo

Oct 07, 2025

Oct 07, 2025

Esperion announces proposed public offering of common stock - MarketScreener

Oct 07, 2025

Oct 07, 2025

ESPR Settles Nexletol/Nexlizet Patent Litigation With RDY, Stock Up - MSN

Oct 07, 2025

Oct 07, 2025

Esperion launches public offering of common stock to raise capital By Investing.com - Investing.com Canada

Oct 07, 2025

Oct 07, 2025

Esperion Therapeutics tumbles after stock offering launch - TradingView

Oct 07, 2025

Oct 07, 2025

Esperion Announces Strategic Expansion Plans for Bempedoic Acid - TipRanks

Oct 07, 2025

Oct 07, 2025

Esperion launches public offering of common stock to raise capital - Investing.com

Oct 07, 2025